WILL YOUR RT-PCR ASSAY IDENTIFY THE NEW SARS-COV-2 VARIANTS? Diagnosing COVID-19 B.1.1.7 and B.1.351 Lineages The UK SARS-CoV-2 variant under investigation (VUI) called VUI 202012/01 (B.1.1.7 lineage) has multiple mutations in the spike glycoprotein’s gene S. Five are amino acid replacements (D614G, A222V, N439K, Y453F and N501Y), and one deletion (del) . The South African variant called 501.V2 [...]
SARS-CoV-2 Diagnostics. Screening. Surveillance. | SARS-CoV-2 testing is a term used for different applications including diagnostics, screening, and surveillance. This post describes the differences between them.
How to Load Barcode Indexes in Illumina® Experiment Manager | The Illumina® Experiment Manager (IEM) is an app used to create valid sample sheets for some Illumina® sequencers. Although sample sheets can be generated manually, this tool minimize the risk of errors.
Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion | Watch our on-demand version of the webinar, Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion.
Reducing Testing Burnout | As of September 1st, the CDC had reported over 79 million COVID-19 tests have been performed in the US since March. The increased testing demands brought on by the COVID-19 pandemic have been causing supply chain shortages for months now.
Multiplexing Libraries Containing Indexes of Different Lengths | Sample multiplexing, also known as multiplex sequencing, allows libraries to be pooled and sequenced simultaneously during a single run on Illumina® instruments.
Accelerating Vaccine Development Using a Next Generation Microfluidic CE Platform | When producing a quality vaccine, all manufacturers must confirm the purity as well as the stability of their formulation and final product.